Levocetirizine Effect on Nasal Nitric Oxide and Nasal Eosinophils in Subjects With Perennial Allergic Rhinitis.
Phase of Trial: Phase IV
Latest Information Update: 31 Oct 2014
At a glance
- Drugs Levocetirizine (Primary)
- Indications Perennial allergic rhinitis
- Focus Pharmacodynamics
- 02 Mar 2010 Results were presented at the 66th Annual Meeting of the American Academy of Allergy, Asthma and Immunology.
- 09 Sep 2009 Actual end date (Aug 2009) added as reported by ClinicalTrials.gov.
- 09 Sep 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History